INSTITUT CLAUDIUS REGAUD
🇫🇷France
SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer
Phase 2
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Other: Surgery aloneDrug: Peri-operative darolutamide + surgery.
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 240
- Registration Number
- NCT05826509
- Locations
- 🇫🇷
Chu Angers, Angers, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷Institut Bergonié, Bordeaux, France
Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Phase 1
Recruiting
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Combination Product: SBRT + MEDI5752
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 20
- Registration Number
- NCT05821231
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷Institut Regional Du Cancer de Montpellier, Montpellier, France
🇫🇷Institut Bergonié, Bordeaux, France
Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae
Not Applicable
Recruiting
- Conditions
- Oropharynx CancerOral Cavity CancerHead and Neck Cancer
- Interventions
- Procedure: Oropharyngeal or oral cavity reconstruction
- First Posted Date
- 2023-03-07
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 40
- Registration Number
- NCT05757817
- Locations
- 🇫🇷
Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O), Toulouse, France
🇫🇷Chu Purpan, Toulouse, France
🇫🇷Chu Gui de Chauliac, Montpellier, France
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Phase 3
Recruiting
- Conditions
- Cervical CarcinomaAdenocarcinomaAdenosquamous Carcinoma
- Interventions
- Procedure: Experimental arm
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 510
- Registration Number
- NCT05581121
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment.
Completed
- Conditions
- ORL Cancer
- Interventions
- Other: Accompaniment by the dental assistant.
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 44
- Registration Number
- NCT05494970
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Not Applicable
Recruiting
- Conditions
- Leiomyosarcoma
- Interventions
- Other: Blood samples will be collected at different times.
- First Posted Date
- 2022-06-22
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 20
- Registration Number
- NCT05427461
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 120
- Registration Number
- NCT05378204
- Locations
- 🇫🇷
Chru de Tours, Tours, France
🇫🇷Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
🇫🇷Centre Leon Berard, Lyon, France
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Recruiting
- Conditions
- Pediatric Solid TumorEpendymoma of Brain
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 370
- Registration Number
- NCT05151718
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, France
Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
Not Applicable
Recruiting
- Conditions
- ORL Cancer
- Interventions
- Other: Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 105
- Registration Number
- NCT04940000
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance
Completed
- Conditions
- Thyroid Cancer
- Interventions
- Other: Metabolites dosage
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 30
- Registration Number
- NCT04821336
- Locations
- 🇫🇷
Institut Claudius regaud IUCT Oncopole, Toulouse, France
© Copyright 2025. All Rights Reserved by MedPath